VERA is the financial translation layer of every Dataix engagement. Where FORT identifies the gap, VERA quantifies what that gap means for enterprise valuation, EBITDA performance, and balance sheet integrity. It was built for one audience: the people who make capital allocation decisions.
Proprietary frameworks working in concert — FORT finds, VERA values
Of diligence protection per dollar of documented closed gap
Of VERA outputs are derived directly from forensic findings — no projections
Every dollar of revenue that falls through a billing integration gap is a dollar that never reaches EBITDA. At the multiples that govern private equity exits and institutional acquisitions, the mathematics of that loss compound quickly. A two million dollar annual billing gap in a platform valued at twelve times EBITDA is a twenty-four million dollar reduction in enterprise value.
Most healthcare organizations have never seen that calculation performed on their own data. FORT produces the findings. VERA performs the translation — converting forensic billing discrepancies into the financial language that governs capital allocation decisions.
The other side of the equation is documentation. Revenue gaps that cannot be recovered — because timely filing limits have closed — still carry value when they are certified and closed. An acquirer cannot use undocumented billing irregularities to renegotiate a purchase price when those irregularities have already been forensically audited and certified by an independent firm.
VERA was built to make both calculations explicit, documented, and defensible in a transaction data room, before the diligence process begins.
The recoverable portion of identified billing gaps flows directly to operating income. VERA maps each gap category to its EBITDA contribution net of recovery costs, giving the organization a documented view of how forensic findings translate to the income statement.
Using the organization's stated or implied exit multiple, VERA translates identified gaps into enterprise value implications at the moment of a transaction, refinancing, or recapitalization event. The calculation is explicit, documented, and tied directly to FORT findings.
Not every gap is recoverable. VERA segments findings by payer type and service date to identify which gaps fall within applicable filing limits and which represent clean-slate documentation value only. The distinction matters for recovery planning and transaction disclosure.
Gaps outside recovery windows still matter. A VERA-certified clean slate means no acquirer, creditor, or regulator encounters undocumented billing irregularities during due diligence. Industry standard: documented closed gaps provide approximately fifteen cents of diligence protection per dollar of identified gap.
Financial projections in healthcare transactions are estimates. They are forward-looking, assumption-dependent, and subject to negotiation. VERA outputs are none of these things. Every figure is derived from data. Every calculation is documented. Every output is traceable to a specific forensic finding in the FORT reconciliation record.
This distinction is consequential in a data room. A projection can be challenged. A certified forensic translation of documented billing discrepancies — audited by an independent firm using a proprietary methodology — is a different class of evidence.
The methodology behind VERA was developed specifically for environments where the audience is not a revenue cycle team but a CFO, a private equity sponsor, a creditor, or an acquirer. Those audiences do not need to understand billing codes. They need a number they can defend — at the board level, in a financing package, at closing.
VERA provides that number. Backed by forensic evidence. Signed by Dataix. Defensible in any institutional context where documentation of revenue integrity carries financial weight.
A certified financial translation of FORT findings. Includes EBITDA impact, enterprise value at risk at stated and market multiples, timely filing segmentation, and clean slate documentation value. Structured for presentation to sponsors, lenders, or acquirers.
A formatted summary showing the step-by-step relationship between forensic billing findings and enterprise value — from identified gap to EBITDA impact to value at multiple. Designed for direct use in transaction materials.
A signed certification by Dataix confirming the scope of forensic review, the findings, and the clean slate status of the analyzed period. Eliminates undocumented billing risk from the diligence process. Suitable for board documentation, data rooms, and regulatory submission.
VERA is deployed before a transaction closes to surface and document all billing integrity findings before an acquirer encounters them independently. A VERA-certified engagement eliminates undocumented billing risk from the diligence process and supports the seller's stated valuation.
Platform and add-on acquisitions in healthcare require revenue integrity certification across multi-site environments. VERA provides the financial documentation sponsors need for LP reporting, debt covenant compliance, and exit preparation.
Identification and certification of recoverable revenue within active Chapter 11 estates. VERA findings are structured for bankruptcy court submission and creditor recovery proceedings where forensic documentation of revenue integrity is a legal requirement.
Lenders and credit facilities increasingly require revenue integrity documentation as a condition of healthcare financing. VERA provides the certified financial evidence that supports borrowing base calculations and debt covenant structures.
“VERA does not produce projections. It produces a certified financial translation of forensic findings. Every figure is derived from data. Every calculation is documented. Every output is defensible in a data room.”